Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis
By J. Healey, A. Baranchuk, E. Crystal, C. Morillo, M. Garfinkle, S. Yusuf, S. Connolly. 2005
735 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/3d23bc598ab19cabdc5de57616239d2a6e791a4d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Camm
- Barbara Riegel
- S. B. Olsson
- Samuel Wann
- Jonathan L. Halperin
- V. Fuster
- Rick A. Nishimura
- A. Budaj
Citations in the corpus
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ (2006, positive): “Inhibition of the RAAS, alone or in combination with other therapies, may prevent the onset or maintenance of AF through several mechanisms (55), including lower atrial pressure and wall stress, prevention of structural remodeling (fibrosis, dilation, and hypertrophy) in both the LA and left ventric”
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “with LV dysfunction and in hypertensive patients with LV hypertrophy.(219,236,237,239,246,250,686) Neprilysin inhibition needs to be studied further, but does not seem to enhance this effect.”
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018, neutral): “RCTs Comparing Obstructive Sleep Apnea (Section 5.4.4) Study Acronym; Author; Year Published Aim of Study; Study Type; Study Size (N) Patient Population Study Intervention (# patients) / Study Comparator (# patients) Endpoint Results (Absolute Event Rates, P value; OR or RR; & 95% CI) Relevant 2° En”